SCHEDULE 13D

Company

NORTHWEST BIOTHERAPEUTICS INC

Filed

September 16, 2015

Accession Number

0001213900-15-007013

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →